» Articles » PMID: 9714781

Use of Deuterium Oxide to Measure De Novo Fatty Acid Synthesis in Normal Subjects Consuming Different Dietary Fatty Acid Composition1

Overview
Specialties Biochemistry
Biophysics
Date 1998 Aug 26
PMID 9714781
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of dietary linoleic (C18:2n-6) and palmitic acids (C16:0) on rate of hepatic de novo fatty acid synthesis was assessed in normal subjects. The diet was formulated to provide combinations of high and low levels of C18:2n-6 and C16:0. After 21 days of diet treatment, plasma triacylglycerol level and incorporation of deuterium into the plasma very low density lipoprotein triacylglycerol (VLDL-TG) pool over 24 hours was measured. Plasma triacylglycerol levels were within the normal range. Increasing dietary intake of linoleic acid decreased plasma triacylglycerol level when subjects consumed a low level of dietary palmitic acid. The relative and net amount of de novo synthesized fatty acid in the plasma VLDL-TG pool was not influenced by the diet treatments. A relationship between plasma triacylglycerol level and rate of hepatic de novo fatty acid synthesis was observed.

Citing Articles

Reduction of De Novo Lipogenesis Mediates Beneficial Effects of Isoenergetic Diets on Fatty Liver: Mechanistic Insights from the MEDEA Randomized Clinical Trial.

Costabile G, Della Pepa G, Salamone D, Luongo D, Naviglio D, Brancato V Nutrients. 2022; 14(10).

PMID: 35631319 PMC: 9143579. DOI: 10.3390/nu14102178.


Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease.

Paglialunga S, Dehn C Lipids Health Dis. 2016; 15(1):159.

PMID: 27640119 PMC: 5027077. DOI: 10.1186/s12944-016-0321-5.


De novo lipogenesis and cholesterol synthesis in humans with long-standing type 1 diabetes are comparable to non-diabetic individuals.

Lambert J, Ryan E, Thomson A, Clandinin M PLoS One. 2013; 8(12):e82530.

PMID: 24376543 PMC: 3871159. DOI: 10.1371/journal.pone.0082530.


Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes.

Wilke M, French M, Goh Y, Ryan E, Jones P, Clandinin M Diabetologia. 2009; 52(8):1628-37.

PMID: 19536518 DOI: 10.1007/s00125-009-1405-9.